Dr_Otto_Lindqvist
I only post when I have a certificate to attach.
72kreputation
224answers
45accepted
17questions
0·5·8badges g·s·b
84tags
120How many freeze-thaw cycles will orforglipron at 20 mg/mL tolerate?accepted · answered 22 Feb 2025 · freeze-thaw, peptide-stability, storage119How many freeze-thaw cycles will orforglipron at 2 mg/mL tolerate?accepted · answered 22 Dec 2024 · freeze-thaw, peptide-stability, storage119Is there any published stability data for orforglipron at minus 80 °C?accepted · answered 1 Jul 2025 · peptide-stability, storage, clinical-trials97Does orforglipron adsorb measurably to the vial wall at 5 mg/mL?accepted · answered 23 Nov 2025 · peptide-stability, content-assay, storage97Is orforglipron at 5 mg/mL stable enough for sixteen weeks of multi-withdrawal use?accepted · answered 24 Sept 2024 · peptide-stability, bacteriostatic-water, shelf-life96Does maintenance at a fraction of the therapeutic dose actually work, and is there any evidence for it?accepted · answered 11 May 2026 · maintenance-dose, discontinuation, clinical-trials95Does racemisation of orforglipron at minus 80 °C show up as a loss of content or of purity?accepted · answered 28 Apr 2025 · peptide-stability, content-assay, purity90How long does orforglipron stay within specification at 37 °C once reconstituted?answered 23 Feb 2025 · peptide-stability, storage, shelf-life90What is the reported incidence of hair thinning on oral semaglutide in PIONEER-1?answered 23 Aug 2024 · hair-loss, clinical-trials, oral-glp186How do I read an impurity table on an orforglipron certificate against the 95.2% headline?accepted · answered 18 Apr 2026 · purity, coa, hplc84Does hydrolysis dominate for orforglipron held at 25 °C?accepted · answered 10 May 2025 · peptide-stability, storage, hplc84My orforglipron vial sat at 25 °C for ten days — is testing worth it before use?accepted · answered 11 Jan 2025 · cold-chain, peptide-stability, batch-testing83My orforglipron vial sat at 40 °C for ten days — is testing worth it before use?answered 3 Jul 2024 · cold-chain, peptide-stability, batch-testing81Is 0.5 mg weekly a defensible maintenance dose for dulaglutide?answered 26 May 2025 · maintenance-dose, clinical-trials, dosing-math81Is fatigue on orforglipron dose-dependent or dose-rate dependent?accepted · answered 25 Jul 2024 · fatigue, titration, orforglipron81Is there any published stability data for orforglipron at 4 °C?accepted · answered 28 Apr 2025 · peptide-stability, storage, clinical-trials81What does 98.8% purity on a C8 column actually tell me about an oral semaglutide vial?accepted · answered 28 Sept 2024 · hplc, purity, coa79Is the top of the ladder the most effective dose, or just the highest one that was studied?accepted · answered 3 Mar 2026 · dose-escalation, clinical-trials, tirzepatide79What did STEP 3 do with participants who could not tolerate a step?accepted · answered 27 Oct 2025 · titration, clinical-trials, gi-side-effects77What happens to orforglipron after eight weeks at 30 °C in solution?answered 1 Feb 2025 · peptide-stability, storage, shelf-life72Is an 18G drawing needle the right choice for drawing orforglipron at 20 mg/mL?accepted · answered 3 Aug 2024 · needle-gauge, injection-technique, dead-space71Does ApoB tell me anything about hepatic fat on retatrutide?answered 23 Jul 2025 · liver-enzymes, mash, bloodwork71What interval makes sense for repeating TSH on dulaglutide?answered 19 Aug 2025 · bloodwork, harm-reduction, a1c69What does the mechanism of a GLP-1 receptor agonist predict that STEP 2 did not test?answered 16 Sept 2024 · glp1-mechanism, clinical-trials, gip-receptor69What should be in place before a first orforglipron vial arrives from Tianjin?answered 27 Sept 2025 · harm-reduction, research-use-only, sterility68What is the lowest maintenance dose with published maintenance data behind it?answered 29 May 2024 · maintenance-dose, clinical-trials, weight-regain67How do I convert the TRIUMPH-1 hazard ratio into an absolute risk reduction?answered 10 Dec 2024 · cardiovascular, clinical-trials, dosing-math66What does orforglipron being a non-peptide small molecule change, practically?answered 27 Feb 2026 · orforglipron, oral-glp1, clinical-trials64What is the reported incidence of reflux on semaglutide in ESSENCE?answered 8 Jan 2025 · gi-side-effects, clinical-trials, semaglutide60Does the ATTAIN-1 population resemble anyone asking about orforglipron here?answered 10 Jun 2024 · clinical-trials, harm-reduction, semaglutide60Is 36 mg weekly a defensible maintenance dose for orforglipron?answered 17 Jul 2024 · maintenance-dose, clinical-trials, dosing-math60Why did my GGT move after four weeks on orforglipron?answered 18 Mar 2025 · bloodwork, kidney-function, lipids57How much of the gross mass of a 2 mg orforglipron vial is actually peptide?accepted · answered 3 Jul 2024 · content-assay, water-content, acetate-content56Does hydrolysis dominate for orforglipron held at 37 °C?answered 3 Aug 2024 · peptide-stability, storage, hplc56Is SELECT a fair comparison of semaglutide against its comparator arm?accepted · answered 28 Dec 2024 · clinical-trials, semaglutide, tirzepatide56Would you re-test orforglipron after eight weeks at minus 20 °C, or accept the original certificate?accepted · answered 16 Jul 2025 · batch-testing, peptide-stability, coa54Does racemisation of orforglipron at 40 °C show up as a loss of content or of purity?accepted · answered 12 Apr 2026 · peptide-stability, content-assay, purity54What fraction of loss on oral semaglutide is lean mass according to SOUL?accepted · answered 3 Jun 2025 · lean-mass, muscle-loss, dexa53My orforglipron vial sat at 4 °C for ten days — is testing worth it before use?answered 20 Mar 2026 · cold-chain, peptide-stability, batch-testing52What happens to orforglipron after eight weeks at 40 °C in solution?answered 20 Jul 2025 · peptide-stability, storage, shelf-life49What interval makes sense for repeating ApoB on orforglipron?accepted · answered 4 Jan 2026 · bloodwork, harm-reduction, a1c48My orforglipron vial sat at minus 20 °C for ten days — is testing worth it before use?answered 14 Jun 2025 · cold-chain, peptide-stability, batch-testing48Does SOUL show oral semaglutide is cardiovascularly equivalent to the injectable?answered 18 Jan 2026 · oral-glp1, semaglutide, cardiovascular48What does SURMOUNT-4 report at the 10 mg dose level?answered 5 Jun 2024 · clinical-trials, dosing-math, titration48Why does compounded orforglipron potency vary between pharmacies?answered 4 May 2025 · compounding, content-assay, coa47Is 4 °C an acceptable storage condition for lyophilised orforglipron?answered 27 Aug 2024 · storage, peptide-stability, shelf-life47Is there any published stability data for survodutide at 2–8 °C?answered 5 Sept 2025 · peptide-stability, storage, clinical-trials45Does oxidation of oral semaglutide at 30 °C show up as a loss of content or of purity?answered 30 Aug 2024 · peptide-stability, content-assay, purity45Is 5 mg weekly a defensible maintenance dose for ecnoglutide?answered 23 Jun 2024 · maintenance-dose, clinical-trials, dosing-math45Is 96.4% a realistic purity ceiling for oral semaglutide given its chain length?answered 21 May 2024 · purity, hplc, peptide-mapping44Is there any published stability data for ecnoglutide at 2–8 °C?accepted · answered 16 Oct 2024 · peptide-stability, storage, clinical-trials44What does FLOW report at the 2.4 mg dose level?accepted · answered 17 Sept 2024 · clinical-trials, dosing-math, titration43Does the PIONEER-1 population resemble anyone asking about oral semaglutide here?accepted · answered 31 Dec 2024 · clinical-trials, harm-reduction, semaglutide43What is the reported incidence of dizziness on oral semaglutide in PIONEER-1?accepted · answered 4 Sept 2024 · clinical-trials, harm-reduction, oral-glp142Is a mini-fridge good enough for storing reconstituted oral semaglutide?answered 3 Jan 2025 · storage, cold-chain, harm-reduction41How do I write up a PeptideMeter result on oral semaglutide so it is useful to others?answered 3 Mar 2025 · batch-testing, coa, harm-reduction41Would you accept 97.6% on orforglipron from QYB without a content assay?accepted · answered 19 Feb 2025 · purity, content-assay, vendor-vetting41Would you accept 98.8% on oral semaglutide from QSC without a content assay?answered 24 Aug 2025 · purity, content-assay, vendor-vetting40Can I reconstitute orforglipron at 8 mg/mL and still measure a small dose accurately?answered 2 Jun 2026 · diluent-volume, insulin-syringe, dosing-math40What does STEP 3 tell me about vomiting at the 2 mg dose?answered 17 Nov 2024 · clinical-trials, vomiting, titration40What does the mechanism of oral semaglutide predict that PIONEER-1 did not test?answered 8 Dec 2024 · glp1-mechanism, clinical-trials, gip-receptor39Does a TFA mobile phase change the purity number I get for orforglipron on a C4 column?accepted · answered 3 Jan 2025 · hplc, purity, reference-standard39Is 50 mg in 2.5 mL of phosphate-buffered diluent a sensible presentation for orforglipron?answered 27 Oct 2024 · diluent-volume, reconstitution, dosing-math38Has anyone independently verified an SGN orforglipron batch COA?accepted · answered 27 Aug 2025 · vendor-vetting, coa, batch-testing38Is ferritin a better monitoring choice than ApoB on orforglipron?accepted · answered 3 Jul 2026 · bloodwork, kidney-function, lipids38Is orforglipron at 8 mg/mL stable enough for sixteen weeks of multi-withdrawal use?answered 20 Mar 2026 · peptide-stability, bacteriostatic-water, shelf-life38What did TRIUMPH-1 do with participants who could not tolerate a step?answered 1 May 2026 · titration, clinical-trials, gi-side-effects38What does 97.1% purity on a C4 column actually tell me about an orforglipron vial?accepted · answered 27 Sept 2025 · hplc, purity, coa38What fraction of loss on orforglipron is lean mass according to ATTAIN-1?answered 9 Dec 2024 · lean-mass, muscle-loss, dexa37Has anyone independently verified a Homopeptide oral semaglutide batch COA?answered 27 May 2025 · vendor-vetting, coa, batch-testing37What does ATTAIN-1 tell me about injection-site erythema at the 36 mg dose?answered 15 Apr 2026 · clinical-trials, injection-site-reaction, titration37What is the reported incidence of early satiety on oral semaglutide in SOUL?answered 24 Jul 2024 · gi-side-effects, clinical-trials, oral-glp135Is a 31G needle the right choice for drawing orforglipron at 5 mg/mL?answered 30 Jan 2025 · needle-gauge, injection-technique, dead-space35Would you accept 98.2% on orforglipron from SSA without a content assay?answered 23 Oct 2025 · purity, content-assay, vendor-vetting34What does TRIUMPH-3 report at the 8 mg dose level?answered 11 Jun 2025 · clinical-trials, dosing-math, titration33How do I reconcile 97.1% from Janoshik with 98.4% from the supplier?answered 4 May 2026 · purity, batch-testing, coa33Is there any published stability data for survodutide at 37 °C?answered 7 Dec 2024 · peptide-stability, storage, clinical-trials32Is SOUL a fair comparison of oral semaglutide against its comparator arm?answered 12 Aug 2025 · clinical-trials, semaglutide, tirzepatide32What did the placebo arm of STEP 5 report for nausea?answered 26 Feb 2026 · clinical-trials, nausea32What does 99.4% purity on a C4 column actually tell me about an orforglipron vial?answered 12 Mar 2025 · hplc, purity, coa32What does a 503A pharmacy need to prepare oral semaglutide lawfully?answered 9 Apr 2025 · pharmacy-503a, compounding, coa32What is the reported incidence of hair thinning on semaglutide in FLOW?answered 29 Jul 2024 · hair-loss, clinical-trials, semaglutide31Is an insulated cool box good enough for storing reconstituted orforglipron?accepted · answered 12 Mar 2025 · storage, cold-chain, harm-reduction31What did the placebo arm of STEP 2 report for reflux?answered 27 Nov 2024 · clinical-trials, gi-side-effects30Does testing every lot make sense, or every third lot?answered 3 Sept 2025 · batch-testing, cost-analysis, harm-reduction30How do I check that two KP lots of orforglipron agree on content assay?answered 30 Jun 2025 · batch-testing, content-assay, vendor-vetting30What is the lowest maintenance dose with published maintenance data behind it?answered 9 Jun 2024 · maintenance-dose, clinical-trials, weight-regain30What is the real-world lead time from Qingdao to Ireland in winter?answered 6 Sept 2025 · international-shipping, cold-chain, customs30What should be in place before a first orforglipron vial arrives from Zhuhai?answered 21 Oct 2024 · harm-reduction, research-use-only, sterility29How many freeze-thaw cycles will oral semaglutide at 1 mg/mL tolerate?answered 4 Jun 2025 · freeze-thaw, peptide-stability, storage29If an orforglipron dose is missed by fourteen days, does the ladder reset?answered 25 Apr 2026 · missed-dose, titration, dosing-math29Is 96.8% a realistic purity ceiling for orforglipron given its chain length?answered 12 Jul 2026 · purity, hplc, peptide-mapping29Is there a pharmacokinetic case for moving oral semaglutide injection day by ten days?answered 5 Aug 2024 · missed-dose, glp1-mechanism, dosing-math29What is the arithmetic to convert 20 mg in 2 mL into units on a U-100 scale?answered 29 Sept 2024 · dosing-math, insulin-syringe, reconstitution29What is the real-world lead time from Tianjin to Finland in winter?answered 11 Nov 2024 · international-shipping, cold-chain, customs28Does oxidation of oral semaglutide at minus 80 °C show up as a loss of content or of purity?answered 23 Aug 2025 · peptide-stability, content-assay, purity28Does racemisation of orforglipron at 37 °C show up as a loss of content or of purity?answered 2 May 2026 · peptide-stability, content-assay, purity28How would I detect fibrillation in a survodutide vial without sending it to Medutest?answered 23 Aug 2024 · vial-inspection, peptide-stability, harm-reduction28Is 24 mg weekly a defensible maintenance dose for orforglipron?accepted · answered 24 Sept 2024 · maintenance-dose, clinical-trials, dosing-math28Is an 18G drawing needle the right choice for drawing orforglipron at 2 mg/mL?answered 18 Jun 2026 · needle-gauge, injection-technique, dead-space28What did the placebo arm of PIONEER-4 report for dizziness?accepted · answered 13 Jun 2025 · clinical-trials, harm-reduction28What is the reported incidence of vomiting on oral semaglutide in PIONEER-1?answered 16 Nov 2024 · vomiting, clinical-trials, oral-glp128Would you accept 98.8% on orforglipron from GL Biochem without a content assay?accepted · answered 10 Jan 2026 · purity, content-assay, vendor-vetting27Is 7.5 mg weekly a defensible maintenance dose for a GLP-1 receptor agonist?answered 29 Apr 2025 · maintenance-dose, clinical-trials, dosing-math27What does SOUL report at the 25 mg dose level?answered 27 Aug 2024 · clinical-trials, dosing-math, titration27What does the mechanism of a GLP-1 receptor agonist predict that ESSENCE did not test?answered 18 Sept 2024 · glp1-mechanism, clinical-trials, gip-receptor27What is "food noise" mechanistically, and which brain regions is the drug actually acting on?answered 5 Jan 2025 · food-noise, glp1-mechanism, clinical-trials27What happens to orforglipron after two weeks at 37 °C in solution?answered 29 Jan 2025 · peptide-stability, storage, shelf-life26Does a formic acid mobile phase change the purity number I get for cagrilintide on a wide-pore C18 column?answered 10 Sept 2024 · hplc, purity, reference-standard26How comparable are liraglutide and tirzepatide on the evidence available?accepted · answered 14 May 2025 · clinical-trials, semaglutide, tirzepatide26Is there a pharmacokinetic case for moving semaglutide injection day by seven days?answered 27 Feb 2025 · missed-dose, glp1-mechanism, dosing-math26Why does deamidation accelerate at room temperature rather than proceeding linearly?answered 11 Mar 2025 · peptide-stability, storage, hplc25How do I convert the TRIUMPH-1 hazard ratio into an absolute risk reduction?answered 29 Nov 2024 · cardiovascular, clinical-trials, dosing-math25Is a titration interval of sixteen weeks better supported than four weeks for oral semaglutide?answered 24 Sept 2024 · titration, dose-escalation, clinical-trials24Is lipase a better monitoring choice than potassium on survodutide?answered 21 May 2025 · bloodwork, kidney-function, lipids24Is there a pharmacokinetic case for moving orforglipron injection day by three days?answered 11 Aug 2025 · missed-dose, glp1-mechanism, dosing-math24What did the placebo arm of SURMOUNT-2 report for fatigue?answered 31 Mar 2025 · clinical-trials, fatigue23Can I reconstitute oral semaglutide at 10 mg/mL and still measure a small dose accurately?answered 10 Oct 2024 · diluent-volume, insulin-syringe, dosing-math23Does hydrolysis dominate for orforglipron held at 4 °C?accepted · answered 11 Jun 2026 · peptide-stability, storage, hplc23How do I convert the ESSENCE hazard ratio into an absolute risk reduction?answered 5 Apr 2026 · cardiovascular, clinical-trials, dosing-math